Close
Nordic 9Nordic 9

Bluebird Ventures (investor - Venture Capital)

United States bluebirdvc.com
See something wrong or missing? Let us know
Offices:Palo Alto
Average round investment:140M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Netherlands Leyden Labs
Mostly invests in: Netherlands Netherlands (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Bluebird Ventures

Name Criteria
Denmark ATP
70%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Sweden AP3
70%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Hitachi Ventures
70%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Subversive Capital
70%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Fearless Ventures
70%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Falcon Edge Capital
70%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Pura Vida Pro LLC
70%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Highline Capital
70%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Legal & General
70%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Japan Nikon
70%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top